SETO Holdings, Inc. (SETO)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
SETO Holdings, Inc. (SETO) trades at $0.01. SETO Holdings, Inc. is a development stage healthcare services company focused on surgical centers, diabetes clinics, and hearing care. Market cap: $103,534, Sector: Healthcare.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for SETO: SETO does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SETO against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
SETO: 1/1 perspectives are bearish.
How is this calculated? →SETO Holdings, Inc. (SETO) Healthcare & Pipeline Overview
SETO Holdings, Inc., operating in the healthcare sector, is in the development stage, focusing on establishing surgical centers, diabetes clinics, and hearing care facilities primarily in the Mid-Atlantic region. It also has plans for international expansion with a hospital project in India, but faces challenges typical of early-stage companies.
What Is the Investment Thesis for SETO?
SETO Holdings, Inc. presents a high-risk, high-reward investment opportunity given its development stage status and ambitious expansion plans. Key value drivers include the successful establishment and operation of its surgical center in Maryland and the four planned diabetes clinics. The company's expansion into India represents a significant growth catalyst, but also introduces substantial operational and financial risks. With a negative profit margin of -382505.9% and a negative gross margin of -319.2%, the company's financial performance requires significant improvement to justify investment. Investors should closely monitor the progress of its development projects and its ability to secure funding and achieve profitability.
Based on FMP financials and quantitative analysis
SETO Key Highlights
- SETO Holdings, Inc. is a development stage company focused on healthcare services.
- The company's Health division is developing a surgical center in Maryland and four diabetes clinics.
- SETO's Hearing Care Group operates 15 clinics in the Mid-Atlantic region.
- The company is engaged in a project to establish a hospital facility in India.
- SETO Holdings, Inc. has a negative profit margin of -382505.9%.
Who Are SETO's Competitors?
SETO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| HWAIF Healwell AI Inc. | $0.53 | -3.52% | $160.75M | 65 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.35M | 63 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
| SLHGP Skylight Health Group Inc. | $12.00 | -5.88% | 61 | |
| NWKHY Netcare Limited | $7.17 | +0.00% | $843.64M | 50 |
| AONC American Oncology Network, Inc. | $10.00 | +0.00% | $292.48M | 50 |
| DCGO DocGo Inc. | $0.59 | +5.81% | $58.07M | 51 |
| JYNT The Joint Corp. | $9.16 | +2.10% | $130.55M | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SETO's Key Strengths?
- Established Hearing Care Group with 15 clinics.
- Focus on developing surgical centers and diabetes clinics.
- Potential for expansion into India.
- Experienced management team.
What Are SETO's Weaknesses?
- Development stage company with limited operating history.
- Negative profit margin and gross margin.
- Reliance on securing funding for expansion projects.
- Limited brand recognition.
What Could Drive SETO Stock Higher?
- Completion and opening of the surgical center in Maryland.
- Establishment of the four diabetes clinics.
- Efforts to establish a hospital facility in India.
- Expansion of the Hearing Care Group through acquisitions or new clinic openings.
What Are the Key Risks for SETO?
- Financial-distress signal — its Altman Z-Score of -26.90 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-15.4%) — the business is not currently generating profit on shareholder capital.
- Difficulty in securing funding for expansion projects.
- Regulatory hurdles and compliance requirements.
- Competition from established healthcare providers.
- Negative profit margin and gross margin.
- Limited operating history and brand recognition.
What Are the Growth Opportunities for SETO?
- Expansion of Diabetes Clinics: SETO's plan to establish four diabetes clinics presents a significant growth opportunity. The global diabetes care devices market is projected to reach $39.6 billion by 2027, driven by the increasing prevalence of diabetes. Successful establishment and operation of these clinics could generate substantial revenue and improve the company's financial performance. The timeline for this growth opportunity depends on securing funding, obtaining regulatory approvals, and effectively marketing the clinics to patients and healthcare providers.
- Development of Surgical Center in Maryland: The development of a surgical center in Maryland represents a key growth driver for SETO. The surgical center market is experiencing growth due to advancements in surgical techniques and increasing demand for outpatient procedures. Successful completion and operation of the surgical center could generate significant revenue and enhance the company's reputation. The timeline for this growth opportunity depends on securing funding, obtaining regulatory approvals, and attracting skilled surgeons and medical staff.
- Growth in Hearing Care Group: SETO's Hearing Care Group, with its 15 clinics in the Mid-Atlantic region, offers a stable base for growth. The global hearing aids market is projected to reach $10.88 billion by 2032. By expanding its service offerings, improving marketing efforts, and acquiring additional clinics, SETO can increase its market share and revenue in the hearing care segment. The timeline for this growth opportunity depends on effective management of existing clinics and successful integration of any acquired clinics.
- Establishment of Hospital Facility in India: SETO's involvement in establishing a hospital facility in India represents a significant long-term growth opportunity. The Indian healthcare market is experiencing rapid growth due to increasing healthcare awareness and improving access to medical services. Successful establishment and operation of the hospital could generate substantial revenue and establish SETO's presence in a high-growth market. However, this project also carries significant risks, including regulatory hurdles, cultural differences, and competition from established players.
- Strategic Partnerships and Acquisitions: SETO can pursue growth through strategic partnerships and acquisitions. By partnering with other healthcare providers, SETO can expand its service offerings and geographic reach. Acquisitions of complementary businesses can also accelerate growth and enhance the company's competitive position. The success of this growth opportunity depends on identifying suitable partners and acquisition targets, negotiating favorable terms, and effectively integrating acquired businesses.
What Opportunities Does SETO Have?
- Growing demand for healthcare services in the Mid-Atlantic region.
- Increasing prevalence of diabetes and hearing loss.
- Potential for strategic partnerships and acquisitions.
- Expansion into new geographic markets.
What Threats Does SETO Face?
- Competition from established healthcare providers.
- Regulatory hurdles and compliance requirements.
- Economic downturn and reduced healthcare spending.
- Difficulty in securing funding for expansion projects.
What Are SETO's Competitive Advantages?
- Established presence in the Mid-Atlantic region through its Hearing Care Group.
- Focus on niche healthcare services such as diabetes care and hearing care.
- Potential for geographic expansion into India.
What Does SETO Do?
Founded in 2004 and based in Hanover, Maryland, SETO Holdings, Inc. is a development stage company providing healthcare services. The company's Health division is focused on delivering healthcare services throughout the Mid-Atlantic region of the United States. A key initiative involves the development of a surgical center in Maryland. Furthermore, SETO is working to establish four diabetes clinics, leveraging its existing locations and collaborating with other healthcare practitioners. In addition to its Health division, SETO Holdings operates a Hearing Care Group, which provides hearing healthcare services through its 15 clinics located in the Mid-Atlantic region. Beyond its domestic operations, SETO Holdings is also pursuing an international project to help establish a hospital facility in India, indicating a broader vision for growth and service delivery. As a development stage company, SETO faces the challenges of securing funding, navigating regulatory hurdles, and establishing a strong market presence.
What Products and Services Does SETO Offer?
- Develops and operates healthcare facilities.
- Provides healthcare services in the Mid-Atlantic region of the United States.
- Operates a Hearing Care Group with 15 clinics.
- Focuses on establishing surgical centers and diabetes clinics.
- Engages in establishing a hospital facility in India.
- Offers hearing healthcare services through its clinics.
How Does SETO Make Money?
- Generates revenue through healthcare service fees.
- Operates surgical centers, diabetes clinics, and hearing care clinics.
- Seeks to expand its service offerings and geographic reach through development projects and partnerships.
What Industry Does SETO Operate In?
SETO Holdings, Inc. operates within the medical care facilities industry, a sector experiencing growth due to an aging population and increasing demand for healthcare services. The industry is characterized by a mix of large, established players and smaller, emerging companies. SETO's focus on surgical centers, diabetes clinics, and hearing care positions it within specific niches of the broader healthcare market. Competitors like ACGI, BBBT, BRAXF, GCAN, and JNHMF operate in similar or adjacent segments. The success of SETO depends on its ability to effectively compete in these markets and execute its expansion plans.
Who Are SETO's Key Customers?
- Patients seeking healthcare services in the Mid-Atlantic region.
- Individuals requiring hearing healthcare services.
- Healthcare providers and practitioners seeking partnerships.
How SETO Holdings, Inc. Is Valued
SETO Holdings, Inc. carries a market capitalization of 104K, placing it in the micro-cap category.
Company Profile
SETO Holdings, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Hanover, US. The company is led by CEO Janon Costley. SETO has traded publicly since 1998.
ROE -15%Key Financial Metrics
Return on equity for SETO Holdings, Inc. stands at -15.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -10.1%, showing how much profit it generates from its asset base. Its free cash flow yield is -49.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.33 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -41.9%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 4/9Financial Health
SETO Holdings, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -26.90 places it in the distress zone, a signal of elevated financial risk.
SETO Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Established Hearing Care Group with 15 clinics.
- Focus on developing surgical centers and diabetes clinics.
- Potential for expansion into India.
- Experienced management team.
Bear Case
- Development stage company with limited operating history.
- Negative profit margin and gross margin.
- Reliance on securing funding for expansion projects.
- Limited brand recognition.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
SETO Latest News
No recent news available for SETO.
SETO Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SETO.
Price Targets
Wall Street price target analysis for SETO.
SETO MoonshotScore
What does this score mean?
The MoonshotScore rates SETO's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Janon Costley
CEO
Janon Costley serves as the CEO of SETO Holdings, Inc. His background includes experience in healthcare management and business development. Prior to joining SETO Holdings, he held leadership positions in various healthcare organizations, focusing on strategic planning, operational efficiency, and revenue growth. He possesses a strong understanding of the healthcare industry and a proven track record of driving business success.
Track Record: Under Janon Costley's leadership, SETO Holdings has focused on developing its healthcare service offerings and expanding its geographic reach. Key initiatives include the development of a surgical center in Maryland and the establishment of diabetes clinics. He has also overseen the company's efforts to establish a hospital facility in India. His strategic decisions have been instrumental in shaping the company's growth trajectory.
SETO OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that SETO Holdings, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Low trading volume and liquidity.
- Potential for price manipulation and fraud.
- Higher risk of delisting or going out of business.
- Limited regulatory oversight.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's liquidity and trading volume.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal proceedings against the company.
- Company has been in business since 2004.
- Focus on healthcare services, a sector with growing demand.
- Plans for expansion into new markets, such as India.
What Investors Ask About SETO Holdings, Inc. (SETO) — Healthcare
What does SETO Holdings, Inc. do?
SETO Holdings, Inc. is a development stage company focused on providing healthcare services. The company operates through its Health division, which is developing a surgical center in Maryland and four diabetes clinics in the Mid-Atlantic region. Additionally, SETO operates a Hearing Care Group with 15 clinics. The company is also involved in a project to establish a hospital facility in India, indicating a broader vision for growth and service delivery in the healthcare sector.
What do analysts say about SETO stock?
As of 2026-03-18, there is no available analyst coverage for SETO Holdings, Inc. This lack of coverage is typical for OTC-listed companies, especially those in the development stage. Investors should conduct their own thorough research and due diligence before investing in SETO. Key valuation metrics, such as price-to-earnings ratio and price-to-sales ratio, are not meaningful due to the company's negative profitability. Growth considerations should focus on the company's ability to secure funding, complete its development projects, and achieve profitability.
What are the main risks for SETO?
The main risks for SETO Holdings, Inc. include its development stage status, negative profit margin, and reliance on securing funding for expansion projects. The company faces competition from established healthcare providers and regulatory hurdles in the healthcare industry. Additionally, the company's expansion into India carries significant operational and financial risks. As an OTC-listed company, SETO is subject to limited regulatory oversight and may experience low trading volume and liquidity.
What are the key factors to evaluate for SETO?
Evaluate SETO on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does SETO data refresh on this page?
SETO prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven SETO's recent stock price performance?
SETO Holdings, Inc. (SETO) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established Hearing Care Group with 15 clinics. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SETO overvalued or undervalued right now?
Valuing SETO Holdings, Inc. (SETO) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying SETO?
Before investing in SETO Holdings, Inc. (SETO), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available company data and may be limited due to the company's development stage status and OTC listing.
- AI analysis is pending and may provide additional insights in the future.